Onyx Biotec Limited is an Indian company that operates in the biotechnology and pharmaceutical sectors. The company is involved in the development, manufacturing, and marketing of biotechnological products, including pharmaceuticals, healthcare solutions, and possibly other related products.
Key Details:
- Industry: Biotechnology, Pharmaceuticals
- Services/Products: Likely focuses on biopharmaceuticals, healthcare products, or diagnostic tools (specific offerings would depend on the company’s focus, such as biosimilars, vaccines, or therapeutic solutions).
- Sector: Life Sciences, Biotechnology Research and Development
- Business Model: Likely involved in the development of innovative biotech solutions, with possible emphasis on research, manufacturing, and distribution.
For detailed information about their specific products, partnerships, or financials, checking their official website or business directories might be useful.
Onyx Biotec IPO Details
| IPO Date | November 13, 2024 to November 18, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹58 to ₹61 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 4,810,000 shares (aggregating up to ₹29.34 Cr) |
| Fresh Issue | 4,810,000 shares (aggregating up to ₹29.34 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 13,322,200 |
| Share holding post issue | 18,132,200 |
| Market Maker portion | 244,000 shares |
Onyx Biotec IPO Reservation
Onyx Biotec IPO offers 48,10,000 shares. 9,12,000 (18.96%) to QIB, 6,88,000 (14.3%) to NII, 16,00,000 (33.26%) to RII and 13,66,000 (28.4%) to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | 13,66,000 (28.4%) |
| Market Maker Shares Offered | 2,44,000 (5.07%) |
| QIB Shares Offered | 9,12,000 (18.96%) |
| NII (HNI) Shares Offered | 6,88,000 (14.3%) |
| Retail Shares Offered | 16,00,000 (33.26%) |
| Total Shares Offered | 48,10,000 (100%) |
Onyx Biotec IPO Anchor Investors Details
Onyx Biotec IPO raises Rs 8.33 crore from anchor investors. Onyx Biotec IPO Anchor bid date is November 12, 2024. Onyx Biotec IPO Anchor Investors list
| Bid Date | November 12, 2024 |
| Shares Offered | 1,366,000 |
| Anchor Portion Size (In Cr.) | 8.33 |
| Anchor lock-in period end date for 50% shares (30 Days) | December 19, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | February 17, 2025 |
Onyx Biotec IPO Timeline (Tentative Schedule)
Onyx Biotec IPO opens on November 13, 2024, and closes on November 18, 2024.
| IPO Open Date | Wednesday, November 13, 2024 |
| IPO Close Date | Monday, November 18, 2024 |
| Basis of Allotment | Tuesday, November 19, 2024 |
| Initiation of Refunds | Wednesday, November 20, 2024 |
| Credit of Shares to Demat | Wednesday, November 20, 2024 |
| Listing Date | Thursday, November 21, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on November 18, 2024 |
Onyx Biotec IPO Lot Size
Investors can bid for a minimum of 2000 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹122,000 |
| Retail (Max) | 1 | 2000 | ₹122,000 |
| HNI (Min) | 2 | 4,000 | ₹244,000 |
Onyx Biotec IPO Promoter Holding
The Promoters of the company are Sanjay Jain, Naresh Kumar and Fateh Pal Singh.
| Share Holding Pre Issue | 88.60% |
| Share Holding Post Issue |